Zobrazeno 51 - 60
of 236
pro vyhledávání: '"Sarah L. Mott"'
Autor:
Kendrick Yim, Kevin Melnick, Sarah L. Mott, Vani Gupta, Timothy N. Clinton, Filipe L.F. Carvalho, Matthew Mossanen, Graeme S. Steele, Kent Mouw, Michael A. O'Donnell, Mark A. Preston
Publikováno v:
Journal of Urology. 207
Autor:
Ian M. McElree, Vignesh T. Packiam, Ryan L. Steinberg, Sarah L. Mott, Paul T. Gellhaus, Kenneth G. Nepple, Michael A. O'Donnell
Publikováno v:
Journal of Urology. 207
Autor:
Phani T. Chevuru, Ian M. McElree, Alexander C. Martin, Jordan R. Richards, Sarah L. Mott, Paul T. Gellhaus, Kenneth G. Nepple, Ryan L. Steinberg, Michael A. O'Donnell, Vignesh T. Packiam
Publikováno v:
Journal of Urology. 207
Publikováno v:
Urologic oncology. 40(11)
To re-evaluate the treatment of T1HG bladder cancer by analyzing our experience over 18 years.An IRB-approved, single-institution retrospective review was performed of all patients with T1HG bladder cancer between August 1999 and July 2017. We assess
Publikováno v:
Translational andrology and urology. 11(9)
Androgen deprivation therapy (ADT) remains a cornerstone of treatment for advanced prostate cancer. Few men elect for surgical castration via bilateral orchiectomy. We sought to compare the relative difference in financial charges between chemical an
Autor:
Jordan Mattson, Mackenzie Thayer, Abbey J Hardy-Fairbanks, Sarah L. Mott, Yasmin A. Lyons, Emily K. Hill
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 47:1082-1089
OBJECTIVES The primary objective was to evaluate the impact of a multimodal perioperative pain regimen on length of hospital stay for patients undergoing laparotomy with a gynecologic oncologist. METHODS We compared 52 patients who underwent laparoto
Publikováno v:
Oncotarget
Immunotherapy has been established as a standard of care for patients with malignant melanoma, however, the long-term side-effects of immunotherapy are still emerging. Studies over the last decade have documented increasing reports of endocrine dysfu
Publikováno v:
JAMA Network Open. 6:e230849
ImportanceDue to the ongoing bacillus Calmette-Guérin (BCG) shortage, sequential intravesical gemcitabine and docetaxel has been increasingly used as first-line therapy for high-risk non–muscle-invasive bladder cancer (NMIBC). However, data direct
Publikováno v:
Journal of Clinical Oncology. 41:497-497
497 Background: Due to ongoing bacillus Calmette-Guerin (BCG) shortages, sequential intravesical gemcitabine and docetaxel (Gem/Doce) has been increasingly utilized as first-line adjuvant treatment for patients with high-risk non-muscle invasive blad
Autor:
Ailynna Chen, Caitlyn S. Grubbs, Faraaz S. Zafar, Bradley T. Loeffler, Sarah L. Mott, Margaret Carrel, Jennifer G. Powers
Publikováno v:
JAMA Network Open. 6:e2252698
This cohort study evaluates the association of proximity to dermatologic clinicians with stage at diagnosis and cancer-specific survival among adults with cutaneous melanoma in Iowa.